Jade Biosciences (JBIO) Shares Outstanding (2020 - 2026)

Jade Biosciences has reported Shares Outstanding for 7 years, with the latest figure at $49.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 1243.55% year-over-year to $49.3 million; the trailing twelve-month figure through Mar 2026 stood at $49.3 million (up 1243.55% YoY), and the FY2025 full-year result was $49.3 million, up 1242.75% from the prior year.
• Shares Outstanding for Q1 2026 stood at $49.3 million, roughly flat from $49.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $49.3 million in Q1 2026, with the low at $12622.0 in Q2 2025.
• Historically, Shares Outstanding has averaged $22.3 million across 5 years, with a median of $24.7 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding jumped 9945.6% — and 2025, when it sank 86.84%.
• Jade Biosciences' Shares Outstanding stood at $24.7 million in 2022, then advanced by 12.3% to $27.8 million in 2023, then plunged by 86.77% to $3.7 million in 2024, then jumped by 1242.75% to $49.3 million in 2025, then rose by 0.06% to $49.3 million in 2026.
• The last three Shares Outstanding figures came in at $49.3 million (Q1 2026), $49.3 million (Q4 2025), and $32.6 million (Q3 2025), per Business Quant data.